Reconstruction of Nuclear Reprogramming by Defined Factors

  • Shinya Yamanaka
Conference paper

Embryonic stem (ES) cells are pluripotent stem cells derived from the inner cell mass of blastocyst. The generation of mouse ES cells (Evans et al., 1981; Martin, 1981) resulted in the “knockout mouse” technology (Hooper et al., 1987; Doetschman et al., 1987). The generation of ES cell lines from human blastocyst-stage embryos (Thomson et al., 1998) has opened up the possibility of using these cells in cell transplantation therapies for juvenile diabetes, Parkinson's disease, heart failure, and spinal cord injury. The usage of human embryos and tissue rejection, however, remain a concern for human ES cells. One strategy to overcome such issues is to reprogram the nuclei of differentiated cells to an ES cell-like, pluripo-tent state.


Embryonic Stem Cell Pluripotent Stem Cell Human Embryonic Stem Cell Nuclear Reprogram Cell Transplantation Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635–645.PubMedCrossRefGoogle Scholar
  2. Cowan CA, Atienza J, Melton DA, Eggan K (2005) Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309:1369–1373.PubMedCrossRefGoogle Scholar
  3. Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, Thompson S, Smithies O (1987) Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (Lond) 330:576–578.CrossRefGoogle Scholar
  4. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature (Lond) 292:154–156.CrossRefGoogle Scholar
  5. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (Lond) 326:292–295.CrossRefGoogle Scholar
  6. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN (2006) Myc influences global chromatin structure. EMBO J 25:2723–2734.PubMedCrossRefGoogle Scholar
  7. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Jaenisch JT, Plath K, Hochedlinger K (2007) Directly reprogrammed fibroblasts show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell 1:55–70.PubMedCrossRefGoogle Scholar
  8. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634–7638.PubMedCrossRefGoogle Scholar
  9. Miller RA, Ruddle FH (1976) Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9:45–55.PubMedCrossRefGoogle Scholar
  10. Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, Yagi R, Yagi K, Miyazaki J, Matoba R, Ko MS, Niwa H (2006) Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol 26:7772–7782.PubMedCrossRefGoogle Scholar
  11. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germ-line competent induced pluripotent stem cells. Nature (Lond) 448:313–317.CrossRefGoogle Scholar
  12. Pan G, Thomson JA (2007) Nanog and transcriptional networks in embryonic stem cell pluripo-tency. Cell Res 17:42–49.PubMedCrossRefGoogle Scholar
  13. Rowland BD, Peeper DS (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6:11–23.PubMedCrossRefGoogle Scholar
  14. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA (1997) Embryonic germ cells induce epige-netic reprogramming of somatic nucleus in hybrid cells. EMBO J 16:6510–6520.PubMedCrossRefGoogle Scholar
  15. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T (2001) Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11:1553–1558.PubMedCrossRefGoogle Scholar
  16. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676.PubMedCrossRefGoogle Scholar
  17. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147.PubMedCrossRefGoogle Scholar
  18. Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, Yamanaka S (2003) Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol 23:2699–2708.PubMedCrossRefGoogle Scholar
  19. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (2007) In vitro reprogramming of fibroblasts into a pluripotent ES cell-like state. Nature (Lond) 448:318–324.CrossRefGoogle Scholar
  20. Yu J, Vodyanik MA, He P, Slukvin, II, Thomson JA (2006) Human embryonic stem cells repro-gram myeloid precursors following cell—cell fusion. Stem Cells 24:168–176.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Shinya Yamanaka
    • 1
  1. 1.Center for iPS Cell Research & Application (CiRA) / Institute for Frontier Medical SciencesKyoto UniversityKyotoJapan

Personalised recommendations